Expansion of the Management
Effective July 1, 2022, Dr. Martin Bruckner was appointed authorized signatory and member of the management of MTA. He now represents the company together with the Managing Director.
Martin Bruckner heads the company’s Research and Development division and makes a significant contribution to the successful development of the company thanks to his technical expertise, high quality awareness and great commitment as technical manager.
The appointment of Dr. Bruckner as authorized signatory is an expression of the high level of trust and appreciation in his work for the company.
Management and staff congratulate Dr. Bruckner on this appointment and wish him every success in the further performance of his duties.